Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 25% ± 8% | |
| retinal rod cell | 7 studies | 27% ± 7% | |
| retinal cone cell | 6 studies | 46% ± 13% | |
| natural killer cell | 5 studies | 18% ± 3% | |
| GABAergic neuron | 5 studies | 29% ± 10% | |
| pericyte | 4 studies | 20% ± 2% | |
| epithelial cell | 4 studies | 37% ± 16% | |
| fibroblast | 4 studies | 20% ± 3% | |
| glutamatergic neuron | 4 studies | 39% ± 11% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 7% | |
| endothelial cell of lymphatic vessel | 4 studies | 19% ± 3% | |
| astrocyte | 4 studies | 23% ± 7% | |
| interneuron | 4 studies | 29% ± 15% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 28% ± 14% | |
| extravillous trophoblast | 3 studies | 34% ± 15% | |
| myeloid cell | 3 studies | 19% ± 3% | |
| ciliated cell | 3 studies | 20% ± 2% | |
| dendritic cell | 3 studies | 26% ± 13% | |
| connective tissue cell | 3 studies | 22% ± 3% | |
| basal cell | 3 studies | 40% ± 24% | |
| neuron | 3 studies | 27% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 100% | 2809.81 | 170 / 170 | 100% | 43.30 | 458 / 459 |
| ovary | 100% | 2429.58 | 180 / 180 | 100% | 39.72 | 429 / 430 |
| breast | 100% | 2981.93 | 459 / 459 | 100% | 61.04 | 1115 / 1118 |
| lung | 100% | 2767.86 | 578 / 578 | 100% | 43.34 | 1151 / 1155 |
| brain | 100% | 1923.27 | 2636 / 2642 | 100% | 45.95 | 704 / 705 |
| prostate | 100% | 3094.19 | 244 / 245 | 100% | 56.75 | 502 / 502 |
| thymus | 100% | 2666.95 | 653 / 653 | 99% | 44.46 | 601 / 605 |
| kidney | 100% | 2208.33 | 89 / 89 | 99% | 39.02 | 889 / 901 |
| esophagus | 100% | 3018.50 | 1445 / 1445 | 98% | 53.31 | 180 / 183 |
| bladder | 100% | 3759.24 | 21 / 21 | 98% | 33.42 | 494 / 504 |
| stomach | 100% | 2197.53 | 359 / 359 | 98% | 33.35 | 279 / 286 |
| intestine | 100% | 3743.66 | 964 / 966 | 98% | 34.95 | 515 / 527 |
| pancreas | 98% | 1178.63 | 321 / 328 | 98% | 38.22 | 175 / 178 |
| adrenal gland | 100% | 3293.20 | 258 / 258 | 96% | 34.80 | 221 / 230 |
| skin | 100% | 2418.20 | 1807 / 1809 | 93% | 35.22 | 440 / 472 |
| adipose | 100% | 3174.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3731.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2321.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.38 | 1 / 1 |
| heart | 99% | 1791.11 | 852 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1876.12 | 793 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 34.64 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 23.45 | 27 / 29 |
| liver | 27% | 183.52 | 61 / 226 | 66% | 14.55 | 268 / 406 |
| eye | 0% | 0 | 0 / 0 | 71% | 14.89 | 57 / 80 |
| peripheral blood | 58% | 891.67 | 538 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070936 | Biological process | protein K48-linked ubiquitination |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | UBE2Q2 |
| Protein name | Ubiquitin-conjugating enzyme E2 Q2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) Ubiquitin conjugating enzyme E2 Q2 Alternative protein UBE2Q2 |
| Synonyms | |
| Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination. . |
| Accessions | L8EC84 ENST00000267938.9 [Q8WVN8-1] E9PHD0 H3BV95 ENST00000567921.1 ENST00000426727.6 H3BN94 ENST00000561851.5 [Q8WVN8-3] ENST00000561723.5 ENST00000569423.5 [Q8WVN8-4] Q8WVN8 |